1. Home
  2. ALKS vs BDC Comparison

ALKS vs BDC Comparison

Compare ALKS & BDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • BDC
  • Stock Information
  • Founded
  • ALKS 1987
  • BDC 1902
  • Country
  • ALKS Ireland
  • BDC United States
  • Employees
  • ALKS N/A
  • BDC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • BDC Telecommunications Equipment
  • Sector
  • ALKS Health Care
  • BDC Telecommunications
  • Exchange
  • ALKS Nasdaq
  • BDC Nasdaq
  • Market Cap
  • ALKS 4.5B
  • BDC 4.1B
  • IPO Year
  • ALKS 1991
  • BDC 1993
  • Fundamental
  • Price
  • ALKS $30.13
  • BDC $106.64
  • Analyst Decision
  • ALKS Buy
  • BDC Strong Buy
  • Analyst Count
  • ALKS 12
  • BDC 6
  • Target Price
  • ALKS $38.33
  • BDC $126.83
  • AVG Volume (30 Days)
  • ALKS 2.0M
  • BDC 255.7K
  • Earning Date
  • ALKS 05-01-2025
  • BDC 05-01-2025
  • Dividend Yield
  • ALKS N/A
  • BDC 0.19%
  • EPS Growth
  • ALKS N/A
  • BDC 1.04
  • EPS
  • ALKS 2.09
  • BDC 5.17
  • Revenue
  • ALKS $1,513,770,000.00
  • BDC $2,550,165,000.00
  • Revenue This Year
  • ALKS N/A
  • BDC $9.02
  • Revenue Next Year
  • ALKS $4.09
  • BDC $5.33
  • P/E Ratio
  • ALKS $14.30
  • BDC $20.61
  • Revenue Growth
  • ALKS N/A
  • BDC 5.99
  • 52 Week Low
  • ALKS $22.90
  • BDC $83.18
  • 52 Week High
  • ALKS $36.45
  • BDC $131.82
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 51.87
  • BDC 63.44
  • Support Level
  • ALKS $29.78
  • BDC $102.49
  • Resistance Level
  • ALKS $31.99
  • BDC $109.07
  • Average True Range (ATR)
  • ALKS 1.04
  • BDC 2.88
  • MACD
  • ALKS 0.42
  • BDC 1.15
  • Stochastic Oscillator
  • ALKS 64.09
  • BDC 93.14

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BDC Belden Inc

Belden Inc provides signal transmission products to distributors, end-users, installers, and original equipment manufacturers. The firm operates in two segments - Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions segment is a provider in network infrastructure and broadband solutions, as well as cabling and connectivity solutions for commercial audio/video and security applications. Automation Solutions segment provides network infrastructure and digitization solutions to enable customers to make data-based business decisions. It operates in Americas, EMEA and APAC, out of which maximum revenue from Americas.

Share on Social Networks: